n-(2-chloroethyl)-n-nitrosoacetamide has been researched along with hydrazine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Finch, RA; Penketh, PG; Sartorelli, AC; Shyam, K | 1 |
1 other study(ies) available for n-(2-chloroethyl)-n-nitrosoacetamide and hydrazine
Article | Year |
---|---|
1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity.
Topics: Animals; Antineoplastic Agents; Carmustine; Drug Screening Assays, Antitumor; Female; Humans; Hydrazines; Leukemia L1210; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Nitroso Compounds; Prodrugs; Xenograft Model Antitumor Assays | 2001 |